Skip to main content
spacbrain

Envoy Medical

Closed (deSPAC)

Health Care · fully implantable hearing devices

What it is
Medical Corporation Envoy Medical Corporation, headquartered in White Bear Lake, Minnesota, is a privately held hearing health company focused on providing innovative medical technologies across the hearing loss spectrum
What it’s doing now
Merging with Anzu Special Acquisition Corp I (ANZU) — closed (despac).
What you should know
Data is still being assembled for this company — what is shown below is everything we have verified so far.

The business, per its filings

SEC primary

Medical Corporation Envoy Medical Corporation, headquartered in White Bear Lake, Minnesota, is a privately held hearing health company focused on providing innovative medical technologies across the hearing loss spectrum. Envoy’s technologies are designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they desire. Envoy is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and ultimately quality of life.

Source: S-4/A, accession 0001104659-23-100182

What the company says about itself

Web research — not audited

Envoy Medical is a hearing health company focused on providing innovative technologies across the hearing health spectrum. They have pioneered fully implanted devices for hearing loss, including the Esteem active middle ear implant and the investigational Acclaim cochlear implant.

Markets:
Hearing Health | Hearing Implants
Products:
Esteem active middle ear implant | Acclaim Cochlear Implant
What our web check found

[WEB-INTEL 2026-08-26] 9 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "The financing included $30.0 million in gross proceeds at closing with up to an additional $48.0 million of potential aggregate gross proceeds" [https://www.envoymedical.com/news/envoy-medical-provides-business-update-following-transformative-financing-and-positive-progress-in-clinical-trial] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Envoy Medical (NASDAQ: COCH) has closed an upsized public offering of up to $78 million." [https://www.linkedin.com/posts/chuckbrynelsen_envoy-medical-announces-closing-of-up-to-activity-7428229415353905153-hNON] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Envoy Medical raises $4 million in direct offering to fund operations" [https://www.investing.com/news/company-news/envoy-medical-raises-4-million-in-direct-offering-to-fund-operations-93CH-4276987] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Envoy Medical plans major stock and warrant sale | COCH IPO Registration (S-1)" [https://www.stocktitan.net/sec-filings/COCH/s-1-a-envoy-medical-inc-amends-ipo-registration-statement-4a72d7e88162.html] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Envoy Medical recently closed an upsized public offering for up to $78.0 million. The financing included $30.0 million in gross proceeds at ..." [https://www.nasdaq.com/press-release/envoy-medical-provides-business-update-following-transformative-financing-and] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Breaking New Sound Barriers: Envoy Medical Secures $10 ... funding round, raising $10 million to drive its next phase of innovation and growth." [https://www.trysignalbase.com/news/funding/breaking-new-sound-barriers-envoy-medical-secures-10m-to-revolutionize-fully-implanted-hearing-solutions] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "The combined company will operate under the name "Envoy Medical, Inc." are expected to commence trading on October 2, 2023," [https://www.envoymedical.com/news/envoy-medical-corporation-and-anzu-special-acquisition-corp-i-complete-business-combination] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Anzu Special Acquisition Corp I announced shareholder approval for the merger September 27th; Merger anticipated to close September 29th with ..." [https://www.envoymedical.com/news/envoy-medical-announces-shareholder-approval-on-proposed-merger-with-anzu-special-acquisition-corp-i] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Deal Announced, Apr 18, 2023." [https://www.spacresearch.com/symbol/ANZUU]

Source: https://www.envoymedical.com/ · captured Aug 26, 2026 · marketing claims are reported as claims, never merged into the filed figures above.

The deal it’s entering

Envoy Medical is merging with Anzu Special Acquisition Corp I (ANZU) currently marked Closed (deSPAC).

Headline equity value—
PIPE≈ $10M · unsourced

Structure per SEC accession(s) 0001104659-23-060442. How to read these numbers: headline vs effective valuation · what a definitive agreement commits

What exactly is being valued, and at what

Common questions

Is Envoy Medical going public?

Envoy Medical has an approved merger with the SPAC Anzu Special Acquisition Corp I (ANZU). Deal status: Closed (deSPAC).

Does Envoy Medical have revenue?

The filings we've parsed don't state a usable revenue figure yet; this profile is updated as new documents land.

Educational content, not investment advice.

Other health care deals